These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9789908)

  • 21. Effects of medication history on midlatency auditory evoked responses in schizophrenia.
    Erwin RJ; Shtasel D; Gur RE
    Schizophr Res; 1994 Feb; 11(3):251-8. PubMed ID: 7910754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P50 suppression deficits and psychopathology in Han Chinese patients with schizophrenia.
    Zhu XL; Tan SP; Wang ZR; Zhang JG; Li D; Fan FM; Zhao YL; Zou YZ; Tan YL; Yang F; Zhang XY
    Neurosci Lett; 2017 Jul; 653():346-350. PubMed ID: 28606770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Auditory verbal hallucinations in schizophrenia correlate with P50 gating.
    Smith DM; Grant B; Fisher DJ; Borracci G; Labelle A; Knott VJ
    Clin Neurophysiol; 2013 Jul; 124(7):1329-35. PubMed ID: 23490551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychological and P300 abnormalities in schizophrenics and their relatives.
    Roxborough H; Muir WJ; Blackwood DH; Walker MT; Blackburn IM
    Psychol Med; 1993 May; 23(2):305-14. PubMed ID: 8332646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Auditory sensory gating and catecholamine metabolism in schizophrenic and normal subjects.
    Waldo M; Gerhardt G; Baker N; Drebing C; Adler L; Freedman R
    Psychiatry Res; 1992 Oct; 44(1):21-32. PubMed ID: 1461944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P300, clinical symptoms, and neuropsychological parameters in acute and remitted schizophrenia: a preliminary report.
    Eikmeier G; Lodemann E; Zerbin D; Gastpar M
    Biol Psychiatry; 1992 May; 31(10):1065-9. PubMed ID: 1511077
    [No Abstract]   [Full Text] [Related]  

  • 27. Lack of relationship of auditory gating defects to negative symptoms in schizophrenia.
    Adler LE; Waldo MC; Tatcher A; Cawthra E; Baker N; Freedman R
    Schizophr Res; 1990; 3(2):131-8. PubMed ID: 2278977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral and P3 amplitude enhancement in schizophrenia following feedback training.
    Fukuda M; Niwa S; Hiramatsu K; Hata A; Saitoh O; Hayashida S; Nakagome K; Iwanami A; Sasaki T; Honda H; Itoh K
    Schizophr Res; 1997 Jun; 25(3):231-42. PubMed ID: 9264178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal p50 gating in unmedicated schizophrenia outpatients.
    Arnfred SM; Chen AC; Glenthøj BY; Hemmingsen RP
    Am J Psychiatry; 2003 Dec; 160(12):2236-8. PubMed ID: 14638598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study.
    Javitt DC; Doneshka P; Zylberman I; Ritter W; Vaughan HG
    Biol Psychiatry; 1993 Apr; 33(7):513-9. PubMed ID: 8513035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The P50 component of the auditory evoked potential and subtypes of schizophrenia.
    Boutros N; Zouridakis G; Rustin T; Peabody C; Warner D
    Psychiatry Res; 1993 Jun; 47(3):243-54. PubMed ID: 8372162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired auditory gating and P50 nonsuppression following traumatic brain injury.
    Arciniegas D; Olincy A; Topkoff J; McRae K; Cawthra E; Filley CM; Reite M; Adler LE
    J Neuropsychiatry Clin Neurosci; 2000; 12(1):77-85. PubMed ID: 10678517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cocaine use and the mid-latency auditory evoked responses.
    Boutros N; Campbell D; Petrakis I; Krystal J; Caporale M; Kosten T
    Psychiatry Res; 2000 Oct; 96(2):117-26. PubMed ID: 11063784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Event-related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophrenia.
    Egan MF; Duncan CC; Suddath RL; Kirch DG; Mirsky AF; Wyatt RJ
    Schizophr Res; 1994 Feb; 11(3):259-71. PubMed ID: 7910755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gamma band response may account for poor P50 suppression in schizophrenia.
    Clementz BA; Blumenfeld LD; Cobb S
    Neuroreport; 1997 Dec; 8(18):3889-93. PubMed ID: 9462461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficits in auditory P50 inhibition in obsessive-compulsive disorder.
    Hashimoto T; Shimizu E; Koike K; Orita Y; Suzuki T; Kanahara N; Matsuzawa D; Fukami G; Miyatake R; Shinoda N; Fujisaki M; Shirayama Y; Hashimoto K; Iyo M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):288-96. PubMed ID: 17884267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auditory P300 event-related potentials and neuropsychological performance in schizophrenia and bipolar affective disorder.
    Souza VB; Muir WJ; Walker MT; Glabus MF; Roxborough HM; Sharp CW; Dunan JR; Blackwood DH
    Biol Psychiatry; 1995 Mar; 37(5):300-10. PubMed ID: 7748981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prepulse inhibition and P50 suppression: commonalities and dissociations.
    Oranje B; Geyer MA; Bocker KB; Leon Kenemans J; Verbaten MN
    Psychiatry Res; 2006 Aug; 143(2-3):147-58. PubMed ID: 16879870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulus parameter effects on the P50 evoked response.
    Zouridakis G; Boutros NN
    Biol Psychiatry; 1992 Nov; 32(9):839-41. PubMed ID: 1450298
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuropsychological correlates of an attention-related negative component elicited in an auditory oddball paradigm in schizophrenia.
    Higashima M; Nagasawa T; Oka T; Tsukada T; Okamoto T; Komai Y; Kawasaki Y; Koshino Y
    Neuropsychobiology; 2005; 51(4):177-82. PubMed ID: 15870507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.